Xeris Pharmaceuticals | XERS - 现金及等价物

股票价格
5.44
每天变化
-0.14 -2.51%
每月一次
-17.33%
每年
-6.37%
Q1 预测
5.28


金融业
股票价格
USD
资产
USD 383.53M
现金及等价物
USD 111.04M
销售成本
USD 13.66M
流动资产
USD 240.31M
流动负债
USD 109.57M
债务
USD 257.65M
EBIT
USD 16.77M
EBITDA
USD 25.09M
员工
377
EPS每股收益
USD 0.05
股本和储备
USD 13.69M
销售毛利
USD 72.15M
债务利息支出
USD 7.15M
利息收入
USD 1.16M
贷款资金
USD 220.34M
市值
USD 783.7M
净收入
USD 11.08M
营业费用
USD 69.03M
营业利润
USD 16.77M
普通股股本
USD 166.22M
PE价格收益
2.45K
税前利润
USD 11.08M
销售收入
USD 85.81M
销售和管理费用
USD 42.64M
股票
USD 68.67M
贸易债权人
USD 3.08M
应收帐款人
USD 51.05M


现金及等价物 更改 日
Celltrion KRW 29.65B 799.42B 2025-06
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 51.09M 4.9M 2025-12
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
Eli Lilly USD 7.27B 2.52B 2025-12
Kangmei Pharma CNY 1.18B 278M 2025-09
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Organigram Holdings CAD 7.58M 20.62M 2025-12
Pacira USD 158.54M 10.96M 2025-12
Perrigo USD 432.1M 22.1M 2025-09
Pharma Mar EUR 17.82M 3.78M 2025-12
Qiagen NV USD 1.36B 621.78M 2025-09
Sartorius EUR 389.9M 429.1M 2025-09
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Supernus Pharmaceuticals USD 151.37M 6.66M 2025-09
Tilray USD 264.83M 43.16M 2025-06
Zealand Pharma A/S 4.58B 1.4B 2025-12
Zz Pientze Pharmaceu CNY 1.77B 376.03M 2025-06